个人资料
- 部门： 统计学院
- 性别： 男
- 专业技术职务： 教授
- 毕业院校：
- 学位：
- 学历：
- 联系电话： 021-62233223
- 电子邮箱： jxu@stat.ecnu.edu.cn
- 办公地址： 中山北路校区理科大楼A1712c
- 通讯地址： 上海市中山北路3663号 华东师范大学 统计学院
- 邮编： 200062
- 传真：
工作经历
2004-2005年，加利福尼亚大学河边分校博士后 2005-2006年，Ambion 生物统计师 2006年-，华东师范大学
教育经历
华东师范大学，本科，1999年 美国鲍林格林大学，博士，2004年
个人简介
华东师范大学统计学院教授。2004年美国鲍林格林大学博士，2004-2005年加利福尼亚大学河边分校博士后。2005-2006年Ambion 生物统计师。2006年5月起华东师范大学任教至今。主要研究方向：临床试验, 多元分析,序贯设计。
学术成果
Dufera,A., Xiong,C., and Xu,J. (2023) Simultaneous confidence intervals from randomization tests with application in testing bioequivalence with multiple endpoints, Biometrical Journal, 65, 2200082. Dufera,A., Liu,T., and Xu,J. (2023) Regression models of Pearson correlation coefficient, Statistical Theory and Related Fields, 7, 97-106. Ditzhaus,M., Yu,M., and Xu,J. (2023) Studentized permutation method for comparing restricted mean survival times with small sample from randomized trials, Statistics in Medicine, 42, 2226-2240. Dormuth,I., Liu,T., Xu,J., Pauly,M., and Ditzhaus,M. (2023) A comparative study to alternatives to the log-rank test, Contemporary Clinical Trials, 128, 107165. Zhang,D. and Xu,J. (2023) A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy, Contemporary Clinical Trials, 127, 107203. Xu,J., Zhang,D., and Mu,R. (2022) A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation, BMC Medical Research Methodology, 22, 258. Bizuayehu,S.B. and Xu,J. (2022) Model-free screening for variables with treatment interaction, Statistical Methods in Medical Research, 31, 1845-1859. Bizuayehu,S.B., Li,L., and Xu,J. (2022) Variable screening in multivariate linear regression with high dimensional covariates, Statistical Theory and Related Fields, 6, 241-253. Belay,S.Y., Guo,X., Lin,X., Xia,F., and Xu,J. (2022) Bayesian basket trial design accounting for multiple cutoffs of an ambiguous biomarker, Statistics in Biopharmaceutical Research, 143, 342-348. Dormuth,I., Liu,T., Xu,J., Yu,M., Pauly,M., and Ditzhaus,M. (2022) Which test for crossing survival curves? A user’s guideline, BMC Medical Research Methodology, 22, 34. Mu,R., Xu,J., Tang,R., Kopetz,S., and Yuan,Y. (2022) A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications, Statistics in Medicine, 41, 374-389. Adall,S.W. and Xu,J. (2021) Bayesian shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trial, Pharmaceutical Statistics, 20, 1074-1087. Liu,T., Chen,Z., and Xu,J. (2021) Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in North China: an observational study, Journal of Medical Virology, 93, 6628-6633. Belay,S.Y., Mu,R., and Xu,J. (2021) A Bayesian biosimilar trial design with time-to-event endpoint, Pharmaceutical Statistics, 20, 597-609. Xu,J., Mu,R. and Xiong,C. (2021) A Bayesian stochastic approximation method, Journal of Statistical Planning and Inference, 211, 391-401. Huang,X. and Xu,J. (2020) Estimating individualized treatment rules with risk constraint, Biometrics, 76, 1310-1318. Liu,T., Ditzhaus,M., and Xu,J. (2020) A resampling-based test for two crossing survival curves, Pharmaceutical Statistics, 19, 399-409. Huang,X., Goldberg,Y. and Xu,J. (2019) Multi-category individualized treatment regime using outcome weighted learning, Biometrics, 75, 1216-1227. Mu,R., Yuan,Y., Xu,J., Mandrekar,S.J. and Yin,J. (2019) gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points, Journal of the Royal Statistical Society Series C, 68, 289-308.
|
